UNSPSC 51401511: Ethyl carfluzepate

This classification denotes a benzodiazepine with the molecular formula C20H17ClFN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36M73UIK01, chemically known as 1h-1,4-benzodiazepine-3-carboxylic acid, 2,3-dihydro-7-chloro-5-(2-fluorophenyl)-1-((methylamino)carbonyl)-2-oxo-, ethyl ester but generally known as ethyl carfluzepate, which bears US NIH Compound Identifier 68856. European Medicines Agency schedules Ethyl carfluzepate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07286MIG.

UNSPSC 51401511 Ethyl carfluzepate, a Commodity code, shows a significant disconnect between its nominal scope and current state and local procurement activity. The code's pharmaceutical classification does not align with the recent solicitations appearing under it; the single recent opportunity records a Seminole County, Florida acquisition of naloxone and drug deactivation systems, which fall outside the specific drug compound the code names.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023, at 2:00 pm. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in pricing, provide drug-free workplace certification and E-Verify compliance, and maintain workers' compensation, commercial general liability, and professional liability insurance. The initial contract term is two years with a one-year renewal option, and includes a three-month probationary period allowing termination with or without cause. The procurement may be funded through FEMA, triggering compliance with the Clean Air Act and Federal Water Pollution Control Act. The code shows little relevant recent activity aligned with its pharmaceutical designation; the mismatch between the code and the actual procurement suggests either a tagging error or a significant gap between the UNSPSC taxonomy and current state purchasing behavior for this compound.